intravenous remifentanil analgesia during labor and decreasing maternal respiratory depression with mosaprid
Not Applicable
- Conditions
- pain of labor
- Registration Number
- JPRN-UMIN000021322
- Lead Sponsor
- Kyoto University Department of Gynecology and Obstetrics
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 150
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who can not consent. Patient information can not be obtained necessary for analysis. Patients of less than 22 weeks of pregnancy the fetus is alive. Patients with a merger or a history of a high degree of hypersensitivity reactions to other drugs. Patients with impaired consciousness.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method pain control, the presence or absence of maternal respiratory depression
- Secondary Outcome Measures
Name Time Method Drug administration time, drug bolus administration number of times, the presence or absence of labor induction, patient satisfaction, final delivery mode, Apgar score, the presence or absence of umbilical cord arterial blood pH, birth weight, neonatal complications